NTRA
NASDAQ · Biotechnology
Natera Inc
$310.67
-53.09 (-14.59%)
Performance
1D
—
1W
-18.01%
1M
-22.47%
3M
-2.41%
6M
+52.13%
1Y
+50.35%
YTD
+35.76%
Open$319.99
Previous Close$363.76
Day High$327.53
Day Low$304.00
52W High$437.41
52W Low$181.00
Volume—
Avg Volume2.20M
Market Cap45.18B
P/E Ratio—
EPS$-1.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$380.25
Below
SMA 200
$269.35
Above
RSI (14)
28.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
31 analysts
Price Target
-54.0% upside
Current
$310.67
$310.67
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.45B | 1.74B | 5.13B |
| Net Income | -221,423,310 | -141,193,835 | 875.75M |
| Profit Margin | -9.0% | -8.6% | 17.1% |
| EBITDA | -327,837,389 | -220,664,247 | 1.33B |
| Free Cash Flow | — | — | 778.23M |
| Rev Growth | +41.1% | +41.1% | +14.5% |
| Debt/Equity | 0.05 | 0.05 | 1.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |